Acute Equol Supplementation and Vascular Function in Women With and Without CKD
This study is looking at how a supplement called S-equol might affect blood vessel health in women. Researchers want to see if S-equol can improve how well blood vessels work, especially in women with chronic kidney disease (CKD) and those without it. You might be able to join if you are a woman between 50 and 69 years old and are postmenopausal. The study will compare S-equol to a placebo (an inactive substance) to see if S-equol helps improve a measure of blood vessel function called Brachial Artery Flow-Mediated Dilation. This measurement will be taken at the beginning and then 1, 2, and 3 hours after taking the supplement.
- Study design
- This is an interventional study planning to enroll 38 women. It compares the effects of S-equol to a placebo.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Blood vessel function will be measured at baseline, then 1, 2, and 3 hours after taking the supplement.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Acute Equol Supplementation and Vascular Function in Women With and Without CKD
At a glance
Conditions
NCT06128278
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
University of Colorado Anschutz Medical Campus
Aurora, Coloradostudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Change in Brachial Artery Flow-Mediated DilationBaseline; 1-hour, 2-hours, and 3-hours post ingestion
Flow-mediated dilation of the brachial artery will be performed using ultrasonography and analyzed with a commercially available software package as percent change in diameter from baseline following reactive hyperemia.